Adam

Increase in manufacturing capacity for Vaxzevria (previously COVID-19 Vaccine AstraZeneca)

EMA’s human medicines committee (CHMP) has approved a scale up of manufacturing of Vaxzevria (previously COVID-19 Vaccine AstraZeneca). An existing manufacturing site operated by Universal Farma in Guadalajara, Spain, will add a second filling line for the finished product.

International regulators’ recommendations on COVID-19 vaccines and the Omicron variant

International regulators have published a report today highlighting their discussions on the effectiveness of current vaccines against the COVID-19 Omicron variant, regulatory requirements for a variant vaccine and considerations on clinical study design. The workshop on the global response to the COVID-19 Omicron variant was organised under the umbrella of the International Coalition of Medicines Regulatory Authorities […]

Euro area monthly balance of payments: November 2021

Current account recorded €24 billion surplus in November 2021, up from €19 billion in previous month Current account surplus amounted to €320 billion (2.7% of euro area GDP) in 12 months to November 2021, up from €195 billion (1.7%) one year earlier In financial account, euro area residents’ net acquisitions of non-euro area portfolio investment securities totalled €878 […]